J7295 HCPCS Level II code: Ethinyl estradiol and etonogestrel 0.015mg, 0.12mg per 24 hours; monthly vaginal ring, each
J7295 is the HCPCS code for “Ethinyl estradiol and etonogestrel 0.015mg, 0.12mg per 24 hours; monthly vaginal ring, each” in CMS’s October 2026 release, in effect from Oct 1, 2026.
Official description
J7295Ethinyl estradiol and etonogestrel 0.015mg, 0.12mg per 24 hours; monthly vaginal ring, each
Short description: Eth estr and eton monthly
HCPCS · United States
Medicare details
The indicators CMS publishes with J7295 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Non-covered by Medicare statute
- Medicare pricing
- Service not separately priced by Part B (e.g., services not covered, bundled, used by Part A only, etc.)
- Type of service
- Other medical items or services
- BETOS category
- Undefined codes
- Coverage statute
- 1862(a)(1)
- Added
- Oct 1, 2021
Where J7295 sits
- 1J codesDrugs administered other than orally
- 2Active code J7295Ethinyl estradiol and etonogestrel 0.015mg, 0.12mg per 24 hours; monthly vaginal ring, each
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
What does HCPCS code J7295 mean?
J7295 is the HCPCS code for “Ethinyl estradiol and etonogestrel 0.015mg, 0.12mg per 24 hours; monthly vaginal ring, each” in CMS’s HCPCS Level II October 2026 release.
Does Medicare cover J7295?
CMS lists J7295’s Medicare coverage as “Non-covered by Medicare statute” and its pricing as “Service not separately priced by Part B (e.g., services not covered, bundled, used by Part A only, etc.)”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside J7295
All J codesJ7210Injection, factor viii, (antihemophilic factor, recombinant), (afstyla), 1 i.u.J7211Injection, factor viii, (antihemophilic factor, recombinant), (kovaltry), 1 i.u.J7212Factor viia (antihemophilic factor, recombinant)-jncw (sevenfact), 1 microgramJ7213Injection, coagulation factor ix (recombinant), ixinity, 1 i.u.J7214Injection, factor viii/von willebrand factor complex, recombinant (altuviiio), per factor viii i.u.J7294Segesterone acetate and ethinyl estradiol 0.15mg, 0.013mg per 24 hours; yearly vaginal system, eachJ7296Levonorgestrel-releasing intrauterine contraceptive system, (kyleena), 19.5 mgJ7297Levonorgestrel-releasing intrauterine contraceptive system (liletta), 52 mgJ7298Levonorgestrel-releasing intrauterine contraceptive system (mirena), 52 mgJ7299Intrauterine copper contraceptive (miudella)J7300Intrauterine copper contraceptive (paragard)J7301Levonorgestrel-releasing intrauterine contraceptive system (skyla), 13.5 mg